The DOI matches its Crossref record.
Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform
Abstract
11 beta-Hydroxysteroid dehydrogenase (11 beta HSD) catalyzes the conversion of cortisol to cortisone and plays an important role in the mammalian kidney in regulating cortisol access to the mineralocorticoid receptor. 11 beta HSD-deficient states, such as the syndrome of apparent mineralocorticoid excess (AME), and licorice ingestion result in hypertension in which cortisol acts as a mineralocorticoid. A gene and complementary DNA sequence encoding type I human 11 beta HSD have been described, but this gene is normal in patients with AME. Separate 11 beta HSD isoforms have been described in rat and rabbit kidney, but 11 beta HSD has not been characterized in human kidney. Kinetic analysis of 11 beta HSD activity in human fetal kidney microsomes revealed only a high affinity isoform (apparent Km, 60 nmol/L for cortisol, 13 nmol/L for corticosterone), the activity of which was exclusively nicotinamide adenine dinucleotide (NAD) dependent. No 11-oxo-reductase activity was seen in either renal homogenates or microsomes. 11 beta-Dehydrogenase activity was inhibited by glycyrrhetinic acid (the active ingredient in licorice) in a competitive fashion, with a Ki of 8.7 nmol/L. This 11 beta HSD isoform was clearly distinct from the type I h11 beta HSD enzyme, in that COS-1 cells transfected with type I h11 beta HSD complementary DNA expressed a low affinity (apparent Km, 2.13 mumol/L) isoform, the activity of which was NAD phosphate dependent. 11-Oxo-reductase activity was present in intact transfected cells (apparent Km for cortisone, 0.36 mumol/L), but not in cell lysates. In contrast to the cloned, low affinity, type I h11 beta HSD enzyme, human kidney contains a high affinity NAD-dependent 11 beta HSD isoform. It seems probable that this isoform is responsible for protecting the renal mineralocorticoid receptor from glucocorticoid excess, and a defect in its activity may explain AME.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
“inhibits 11 -HSD2 with an inhibition constant (Ki) of 5–10 nm (73, 107).”
Self-citationNeurosteroids: biosynthesis and function of these novel neuromodulators
Compagnone, N. A., & Mellon, S. H. (2000) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0188 · Cited by 820
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Self-citation11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 718
Self-citationActions of Placental and Fetal Adrenal Steroid Hormones in Primate Pregnancy*
PEPE, G. J., & ALBRECHT, E. D. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-5-608 · Cited by 498
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
Draper, N., & Stewart, P. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06019 · Cited by 375
Self-citationHypertension and the cortisol-cortisone shuttle
Quinkler, M., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030138 · Cited by 286
Self-citationMcTernan, C. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4979 · Cited by 282
Shams, M., Kilby, M. D., Somerset, D. A., Howie, A. J., Gupta, A., Wood, P. J., Afnan, M., & Stewart, P. M. (1998) · Human Reproduction · doi:10.1093/humrep/13.4.799 · Cited by 276
Self-citationBujalska, I. J., Kumar, S., Hewison, M., & Stewart, P. M. (1999) · Endocrinology · doi:10.1210/endo.140.7.6868 · Cited by 254
Self-citationGlucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Seckl, J. R. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.359 · Cited by 239
“11 -HSD1 is expressed in kidneys of rats but negligible expression occurs in adult human kidney (Stewart et al., 1994).”
Storbeck, K.-H., Bloem, L. M., Africander, D., Schloms, L., Swart, P., & Swart, A. C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.006 · Cited by 198
11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196
Self-citationHewitt, K. N., Walker, E. A., & Stewart, P. M. (2005) · Endocrinology · doi:10.1210/en.2005-0117 · Cited by 149
Self-citationHardy, M. P., Sottas, C. M., Ge, R., McKittrick, C. R., Tamashiro, K. L., McEwen, B. S., Haider, S. G., Markham, C. M., Blanchard, R. J., Blanchard, D. C., et al. (2002) · Biology of Reproduction · doi:10.1095/biolreprod.102.006312 · Cited by 122
Giavoli, C., Libé, R., Corbetta, S., Ferrante, E., Lania, A., Arosio, M., Spada, A., & Beck-Peccoz, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1114 · Cited by 97
Apparent mineralocorticoid excess syndrome: an overview
Palermo, M., Quinkler, M., & Stewart, P. M. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500015 · Cited by 92
Self-citationSwart, A. C., & Storbeck, K.-H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.009 · Cited by 68
“Cortisol is able to bind and activate the mineralocorticoid receptor (MR) to the same degree as ALDO and thus its conversion by 11βHSD2 to an inactive steroid, no longer able to bind the MR, is critical as circulating cortisol levels are significantly higher than ALDO levels (Stewart et al., 1994).”
BackgroundWalker, E. A., Clark, A. M., Hewison, M., Ride, J. P., & Stewart, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011142200 · Cited by 65
Self-citationGrapefruit juice and licorice increase cortisol availability in patients with Addison's disease
Methlie, P., Husebye, E. E. S., Hustad, S., Lien, E. A., & Løvås, K. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0518 · Cited by 50
Darnel, A. D., Archer, T. K., & Yang, K. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00116-8 · Cited by 44
Apparent mineralocorticoid excess syndromes
Shimojo, M., & Stewart, P. M. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349763 · Cited by 23
Reduced cortisol metabolism during critical illness.
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1306703 · Cited by 23
Dorin, R. I., Urban, F. K., Perogamvros, I., & Qualls, C. R. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac173 · Cited by 4
Metadata
- Authors
- Stewart, P. M.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1994-08-01
- Volume
- 79
- Issue
- 2
- Pages
- 480-484
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2039153534
- Cited by
- 180
- References
- 0
- FWCI
- 10.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.